A multidisciplinary approach for patients with moderate-to-severe psoriasis: an advisable network of management

Ital J Dermatol Venerol. 2023 Jun;158(3):262-263. doi: 10.23736/S2784-8671.23.07559-X. Epub 2023 May 10.
No abstract available

MeSH terms

  • Antibodies, Monoclonal
  • Humans
  • Patients
  • Psoriasis* / drug therapy

Substances

  • Antibodies, Monoclonal